Pfizer's cardiovascular business highlights the intersection of drug pricing, marketing, patents, and competition in the ...

This past May, Pharmaceutical Executive reported that CVS Health decided to return Eli Lilly’s Zepbound to its list of ...

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

President Donald Trump has announced tariff plans for all imported generic drugs, which experts warn could have implications ...

A new treatment option is available for people with high cholesterol. Lipfendra, manufactured by Merck, is now approved by ...

The Food and Drug Administration has approved a new pill that's been proven to significantly reduce levels of "bad" cholesterol. Clinical trials showed that Lipfendra, manufacture ...

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...

If you are a Medicaid beneficiary who is prescribed a glugacon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes, ...

Dr. Pieter Cohen told Newsweek there is "absolutely not" enough evidence these peptides are safe for human use.

Eli Lilly said Thursday it plans to file for regulatory approval of its next-generation weight loss drug retatrutide in the ...

Not to be confused with statins, this new pill is the first of its kind.

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...